Uncontrolled Growth - Cancer to Dominate the Global Vaccine Market by 2012By: Shushmul Maheshwari
|
Uncontrolled Growth - Cancer to Dominate the Global Vaccine Market by 2012
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
According to our report “Global Vaccine Market Forecast to 2012”, addition of over 12 Million new cancer patients annually and unavailability of an effective treatment has created a strong interest among the pharmaceutical and biotech players in the cancer vaccine segment to come up with the most effective treatment in the shortest time possible. The report estimates that in 2007, the market for cancer vaccines, largely driven by the sales of cervical cancer vaccine Gardasil, reached US$ 2.2 Billion.
This report says that the cervical vaccine segment is expected to be the most lucrative in the cancer vaccine market. Cervical cancer vaccines Gardasil and Cervaix were among the top three bestselling vaccines in 2012. Apart from the cervical cancer segment - melanoma, lung lymphoma and prostate cancer vaccine segments are also seeing high activity with a number of products in late stage of development. However, to repeat the success of Gardasil in the market, each of these vaccines will have to establish its superiority as well as safety in terms of the currently established treatment protocols in order to first win the market approval and later on get reimbursement from health insurance agencies.
A number of new approvals will push the cancer vaccine segment to grow at a CAGR of over 30% between 2007 and 2012, enabling the cancer vaccine segment to occupy more than 26% of the overall global vaccine market in 2012, says the research report.
Apart from cervical vaccines, “Global Vaccine Market Forecast to 2012” also talks about vaccine segments like pneumococcal vaccines, polio vaccines, HIV vaccines, meningitis vaccines and Japanese encephalitis vaccines among others. This report contains market-based research and provides objective analysis on the global vaccine market. It gives a thorough statistical and analytical overview on the global vaccine market, and provides past, present and future data on the market structure and composition. The research extensively discusses the opportunities and challenges that are expected to arise within and from the vaccine market.
For more information visit: http://www.rncos.com/Report/IM153.htm
Current Industry News: http://www.rncos.com/Blog/http://www.rncos.com/ |
|
| Keywords |
Global Vaccine Market Forecast to 2012, Global Vaccine Market, Vaccine Market, Vaccine Industry |
| Category |
Health and Fitness |
| Submission Date |
Dec 2, 2008 |
| Article Contact Name |
Shushmul Maheshwari || send email to Shushmul Maheshwari
|
|
Other links at Health and Fitness |
| 1. |
MV Hospital Promotes Prevention of Childhood Obesity and Diabetes
|
|
|
Hospital for Diabetes & Diabetes Research Centre, Chennai and the WHO collaborating centre in India, launched a campaign titled ‘Campaign on Prevention of Childhood Obesity and Diabetes’ to address this concern. A manual detailing facts and guidelines on prevention of obesity for children was also launched to help cultivate long-term weight control. The manual, an awareness handbook on the subject in the country— Manual on Prevention of Childhood Obesity—was launched by Thangam Thennarasu, Honorable Minister of Education, Tamil Nadu.
Dr Vijay Viswanathan, Managing Director, MV Hospital for Diabetes, said, "The increase of obesity in children in India especially in the urban areas is quite alarming. Therefore, we decided to concentrate on the food habits of children and assist parents in providing their children with a healthy nutritious diet. The manual also has guidelines on physical activity and routines that would not over-stress the child but help stay fit." He requested the Government of Tamil Nadu to support the Institute in performing an impact assessment in the state. The study would form a base for understanding the need for awareness on prevention of childhood obesity and diabetes not just in the state, but for the entire country, he said. "We are planning to submit a memorandum to the Government in this regard and hope to launch the project soon," Dr Viswanathan added.
Goal of treatment for Diabetes :
The main goal of treating diabetes is to lower blood sugar to a normal level. Lowering and controlling blood sugar may help prevent or delay complications of diabetes such as heart disease, kidney disease, blindness and amputation.
High blood sugar can be lowered by diet and exercise and by certain medicines.
Treatment of Type 2 Diabetes with Sitagliptin (Januvia)
Type 2 diabetes is a condition in which body does not make enough insulin, and the insulin that body produces does not work as well as it should. Body can also make too much sugar. When this happens, sugar [glucose] builds up in the blood. This can lead to serious medical problems.
RECENT APPROACH FOR TYPE 2 DIABETES – SITAGLIPTIN (JANUVIA):
*Sitagliptin (Januvia) helps to improve the level of insulin after a meal
*It decreases the amount of sugar made by the body
*It works when blood sugar is high, especially after a meal. This is when the body needs the greatest amount of help in lowering blood sugar. It also lowers blood sugar between meals. *It is unlikely to cause low sugar [Hypoglycemia] because it does not work when blood sugar is low
*It can be used alone or in combination with certain other medicine that lowers blood
sugar along with recommended diet and exercise program
CANNOT BE USED FOR PEOPLE WITH THE FOLLOWING CONDITIONS:
*Type I Diabetes [who needs only insulin]
*Diabetic Ketoacidosis [increased ketones in blood and urine]
*Any kidney problems or any post or present medical problems *Allergy to Sitagliptin
* Children below 18 years of age
* Pregnancy and breast feeding woman
DOSAGES:
*100 mg tablet is available in the market
*Once a day by mouth with or without food
*Diet and exercise can help our body use its blood sugar better. We should follow the
recommended diet, exercise and weight loss program while taking Sitagliptin
SIDE EFFECTS:
Like other medicines, may cause side effects. But it was usually mild and did not cause patient to stop taking Sitagliptin. The side effects reported in patient treated with Sitagliptin were similar to side effects in patient treated with a tablet containing no medication [a placebo].
When used with sulfonylurea like Daonil, low blood sugar [Hypoglycemia] due to sulfonylurea can occur. Lower doses of sulfonylurea medicine may be required.
When Januvia [Sitagliptin] and Metformin [like Glyciphage] were started together the following side effects were reported.
*Diarrhea
*Indigestion
*Flatulence
*Vomiting
*Headache
OTHER EFFECTS OF THE MEDICINE:
*Allergic reaction
*Upper respiratory infection
*Stuffy nose and sore throat
|
| 2. |
RNCOS Releases a New Report- Ukraine Pharma - New Opportunities for Growth
|
|
|
RNCOS has recently added a new Market Research Report titled, “Ukraine Pharma - New Opportunities for Growth” to its report gallery. According to the new research report, Ukraine promises to be one of the most lucrative pharmaceutical markets in the world. In 2007, the Ukrainian pharmaceutical market grew by nearly 21% to register revenues in excess of US$ 2 Billion. The market is characterized by an increasing proportion of imported and high-priced drugs. In 2007, the average unit price of drugs sold in Ukraine increased by nearly 20%, strongly pushing the value of pharmaceutical sales, despite a relatively ordinary growth in sales volume.
The future outlook of the industry also seems very positive as the market is expected to be driven by a number of reforms recently proposed by the government. Factors such as increasing penetration of health insurance and increasing disposable incomes of consumers will also fuel growth. The lack of effective price controls and high margins are also expected to lure foreign players in this market. The country’s unstable political environment, however, will be the biggest hurdle for investments. But overall, the market is expected to grow strongly, exceeding US$ 4.5 Billion in revenues by 2012.
This report gives an extensive and objective analysis on the pharmaceutical market of Ukraine. It investigates both the past and present trends in the market, with its main focus on the future trends shaping the industry. The study discusses the performance of both the retail and hospital segments of the pharmaceutical market in detail and based on various present and future indicators, analyzes the future of these segments. This report gives valuable information to manufacturers/investors planning to enter the Ukrainian pharmaceutical market.
The Report Provides Forecasts on
- Macroeconomic Indicators
- Healthcare Indicators
- Population & Demographics
- Disease Profiles
- Total Pharmaceutical Market
- Retail Pharmaceutical Market
- Hospital Pharmaceutical Market
Key Player Profiling
“Ukraine Pharma - New Opportunities for Growth” provides brief profiling on key players, both domestic and foreign, currently operating in the Ukraine pharmaceutical market. This section describes the revenues and growth of players in the total pharmaceutical market, retail market and hospital market. Performance of key drugs in various segments of the market has also been evaluated. Business profiles of top five players, Berlin Chemie, Sanofi Aventis, Novartis, Arterium and Darnitsa, have also been discussed in this report.
For more information visit: http://rncos.com/Report/IM161.htm
Current Industry News: http://www.rncos.com/Blog/
|
| 3. |
RNCOS Releases a New Report- Booming Clinical Trials Market in India
|
|
|
RNCOS has recently added a new Market Research Report titled, “Booming Clinical Trials Market in India” to its report gallery. According to the new RNCOS report, India promises to be one of the hottest destinations for conducting global clinical research, owing to a huge patient pool representing both chronic and infectious diseases, easy recruitment of patients, and high cost savings.
India presently occupies a very small pie of the global opportunity. The total number of clinical trials in India stood at 221 in 2007, which equates to less than 2% of the global clinical trials. With all major pharmaceutical/biotech companies and CROs establishing their presence in India, the number of clinical trials in the country is expected to grow several folds in the next five years. The country is projected to conduct nearly 5% of the global clinical trials by 2012. However, to achieve its goal of becoming a global hub of clinical trials, the country has to overcome challenges like unethical trials, delay in trial approval, inappropriate protection of clinical data, and lack of Good Clinical Practice (GCP) certified sites and investigators. Surging clinical trials market in India will create enormous opportunities for a number of associated industries, including IVD market, education sector and clinical data management.
“Booming Clinical Trials Market in India” gives an extensive and objective analysis on the Indian clinical trials market. It investigates the advantages/disadvantages India has in becoming a global clinical trials hub. The report exhaustively evaluates and compares the key factors that drug companies and CROs look before outsourcing clinical trials to a country. These include parameters such as patient pool, regulatory environment, cost, infrastructure, human resources and past performance in conducting clinical trials. Thus, this analytical study serves as a useful guide for drug manufacturers, CROs, consultants and investors who are planning to enter the Indian clinical trials market.
Our report provides forecasts on
- Size of global clinical research outsourcing market
- Size of Indian clinical research outsourcing market
- Number of clinical trials in India
- Number of patients expected to participate in clinical trials in India
- Clinical trials infrastructure and professionals in India
- Healthcare indicators in India
Key questions answered in the report
- Why are drug manufacturers outsourcing clinical trials?
- Where and how many clinical trials are being outsourced?
- Where dose India stand in the global clinical trials market?
- How big is the clinical trials opportunity in India?
- How much does it cost on hiring personnel for various clinical research processes, rent and utilities in India as compared to other countries?
- How does clinical trials infrastructure and staff in India vary from other countries?
- What are various government regulations/guidelines for conducting clinical trials in India?
- What are the Future trends predicted to shape the clinical trials market in India?
- How is the clinical trials market impacting associated industries?
Key players analyzed in the report
This section provides business overview on prominent players in the Indian clinical research market like Syngene International Ltd, Quintiles Research (India) Private Limited, Lambda Therapeutic Research Ltd, Vimta Labs Limited and Veeda Clinical Research - India.
For more information visit: http://www.rncos.com/Report/IM564.htm
Current Industry News: http://www.rncos.com/Blog/
|
| 4. |
Hair Myths Revealed here
|
|
|
There are so many different beliefs and viewpoints on hair care and styling that sometimes you can get confused as to which of these are actually true. It even happens sometimes that you get devastated when you discover that the method you have been practicing almost your entire life is a myth.
To avoid this from happening, it is essential that you know some of the common misconceptions or myths about hair so that you do not make the mistake of believing or practicing them. Listed below are some of them.
Myth # 1 - You need to wash your hair daily.
Just like the need to take a bath every day, it sounds sensible to wash your hair daily too. However, you have to know that the latter is not necessary. In fact, doing so can only strip it of the essential oils needed to maintain its healthy gloss and sheen. Even if you plan to use a mild shampoo, it would still be better if you give your tresses a break from shampoo within the week.
Myth # 2 - Shaving your hair can alter its texture.
This is a belief that has long been held by parents who make the mistake of thinking that shaving their baby's scalp will result in a change in hair texture. This is not true. It will remain the same texture even if you go bald. This means that if you detest your frizzy hair, shaving your head is not necessarily the solution because it will not magically grow healthy and shiny afterwards.
Myth # 3 - Constant use of hair equipment can damage it.
This belief actually depends on what kind of equipment you are using. For instance, if you are using FHI irons, then you really have nothing to worry about even if you practically iron your hair thrice a week. However, if you are using cheap generic irons that make use of PTC heaters, which are not capable of sustaining consistent heat, then you will be in a lot of trouble.
Remember, high quality irons and other equipment are equipped with a technology that will not be harmful to your hair. FHI irons, for example, has an adjustable heat setting that allows you to set the temperature ideal for your hair type and texture. Moreover, it emits negative ions that contribute to a healthy glow in your locks.
Myth # 4 - Applying lemon juice on it will lighten your blonde hair.
Lemon juice as a natural lightener is not only ineffective; it is also a waste of time. If you want to lighten your blonde hair, the best way to do it is to go to a salon, consult a professional stylist and find out what kind of coloring treatment will be suitable for you.
Myth # 5 - There is nothing wrong with using hair products that are not ideal for its type.
Many people make the mistake of thinking that using products ideal for another person's hair type is all right. But the truth is, this can contribute to unhealthy hair or worsen a problem if you have one. For example, if you have oily hair, and you used a shampoo for a dry one , a result of this will be greasier hair.
Knowing the difference between a fact and a myth when it comes to hair care and styling will help you go a long way in ensuring that yours is well taken care of.
|
| 5. |
Best Homeopathic Remedies For Asthma
|
|
|
There are many remedies that can be effective in treating allergic reactions, depending upon the type of allergy, time and location of reaction, affinity for warmth or cold, and emotional state. If a remedy is well suited for your condition, your will experience immediate improvement or, in some cases, a healing crisis (a brief worsening of symptoms followed by improvement).
* Arsenicum album: Indicated for dry cough with first sleep, asthma on lying down at night, tickling in throat or sensation that something is stuck; strong, spasmodic cough, constriction of chest, whistling while breathing; frequent sneezing, hay fever accompanied by excessive water nasal discharge and salty, bitter taste in mouth. Also feel raw burning behind sternum; may become drenched with sweat during sleep. Symptoms worsen between 9 p.m. and 11 p.m., after a nap, or being in a draft. Symptoms improve while lying with head high or sitting up.
* Arsenicum album: Indicated for wheezing cough that may be alternately dry and loose; cough worsens during drinking and while lying on back, accompanied by burning in the chest, darting pain in the upper portion of the right lung, bloody sputum, and scanty, frothy expectoration. Feel very restless and anxious, chilly, need for warm water but only drinks in sips; also can't lie down due to fear of suffocation or death. Symptoms worsen between 11:30 p.m. to 3 a.m., when consuming cold drinks, or in cold air.
Ammonium carbobicum: Indicated for severe asthma, accompanied by exhausted breathing, shortness of breath when wheezing, bronchial constriction and congestion, difficulty in expectorating, burning in chest, cough with palpitations, slow labored breathing, bubbling sounds, lung swelling, and slimy sputum with specks of blood. Symptoms worsen around 3 a.m., on cold, cloudy days, in the damp open air, during menstruation. Symptoms improve while eating, lying on abdomen, or in dry weather.
* Aralia racemosa: Indicated for dry cough with first sleep, asthma on lying down at night, tickling in throat or sensation that something is stuck; strong, spasmodic cough, constriction of chest, whistling while breathing; frequent sneezing, hay fever accompanied by excessive water nasal discharge and salty, bitter taste in mouth. Also feel raw burning behind sternum; may become drenched with sweat during sleep. Symptoms worsen between 9 p.m. and 11 p.m., after a nap, or being in a draft. Symptoms improve while lying with head high or sitting up.
|
|
|
